MaxHealth Medicine Group

Established in 2009, the MaxHealth Medical Group works with world-class manufacturers of pharmaceutical products and medical technologies to open up the Chinese market to them. MaxHealth has an interest in medical technologies that can transform existing treatment processes and bring about significant benefits to patient and physicians. The company partners with innovative companies to commercialise medical technologies for the Chinese market through investments, joint ventures and technology licensing.

Tony Miao

CEO

1 past transactions

Zilico

Corporate Round in 2018
Zilico develops medical diagnostic devices using electrical impedance spectroscopy technology. Its primary product, ZedScan, enhances cervical cancer diagnosis by providing real-time, objective assessments alongside colposcopy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.